جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

7 مُخرَج نتائج البحث عن «Aspirin»

مراجعةوصول مفتوح2026

Meta-analysis of Randomized Trials in Emergency and Acute Orthopedic Trauma Comparing Aspirin and Low-Molecular-Weight Heparin for Thromboprophylaxis

Orthopedic Reviews · مجلد 18 · 163922-163922

Background: Venous thromboembolism remains an important complication after acute orthopedic trauma. Low molecular weight heparin has historically been the conventional pharmacologic standard for thromboprophylaxis, while aspirin has gained increasing clinical interest as a practical alternative. This systematic review and meta-analysis evaluated randomized controlled trial evidence comparing aspirin with low molecular weight heparin after acute orthopedic trauma. Methods: PubMed, Scopus, and Web of Science were systematically searched from database inception through March 21, 2026. Randomized controlled trials comparing aspirin with low molecular weight heparin in adults with acute orthopedic trauma requiring thromboprophylaxis were included. Primary outcomes were all cause mortality, bleeding complications, and infection related complications. Quantitative synthesis was performed where appropriate using pooled risk ratios with 95% confidence intervals under a random effects model. Venous thromboembolic outcomes were synthesized qualitatively because of heterogeneous endpoint definitions. Results: Four publications representing two independent randomized orthopedic trauma trial programs involving 12,540 participants were included. Meta analysis showed no statistically significant differences between aspirin and low molecular weight heparin for all cause mortality (risk ratio 1.02, 95% confidence interval 0.69 to 1.53), bleeding complications (risk ratio 0.96, 95% confidence interval 0.88 to 1.05), or infection related complications (risk ratio 1.05, 95% confidence interval 0.80 to 1.37). No statistical heterogeneity was observed across pooled outcomes. Conclusion: Aspirin did not demonstrate statistically significant differences from low molecular weight heparin in mortality or major safety outcomes within the currently available randomized orthopedic trauma evidence. However, comparative venous thromboembolic efficacy remains uncertain because thromboembolic outcomes could not be validly pooled. Further trauma specific randomized studies with standardized outcome reporting are needed.

aspirinlow molecular weight heparinthromboprophylaxisvenous thromboembolism
مراجعةمفتوح (مستودع)2026

The Impact of Body Weight on Aspirin’s Antiplatelet Efficacy: A Narrative Review of Conflicting Evidences and Clinical Implications

Advanced Health Science and Technology Journal · مجلد 2 (1) · 21-26

Abstract Aspirin is one of the oldest and most used anti-platelet medications for the prevention of cardiovascular diseases. There has been conflicting research recently about how body weight affects the antiplatelet effectiveness of aspirin. The purpose of this narrative review was to examine the recent research on the connection between aspirin responsiveness, platelet function, and obesity. To find patterns and discrepancies, pertinent research from PubMed, Scopus, and Google Scholar was rigorously examined and compiled. While some studies showed no discernible effect, others highlighted methodological and population-specific variations by reporting decreased aspirin efficacy in people with higher body weight because of increased platelet reactivity, aspirin deactivation, and altered pharmacokinetics, underscoring the need for well-designed, large-scale clinical investigations. The need for carefully planned, extensive clinical studies is highlighted by the fact that the evidence is still equivocal overall. A better understanding of these mechanisms may support the development of personalized antiplatelet strategies, including tailored aspirin dosing in selected subgroups such as obese patients with high thrombotic risk.

aspirinbody weightobesityantiplatelet efficacy
مقالمفتوح (مستودع)2026

Awareness and Detection of Artificial Intelligence-generated Misinformation in Medical Contexts among Health Professions Students in Riyadh, Saudi Arabia: A Cross-sectional Study

Advanced Health Science and Technology Journal · مجلد 2 (1) · 53-62

Abstract Background: Artificial intelligence (AI) is increasingly used in health care and medical education; however, concerns persist regarding health professions students’ ability to evaluate the accuracy of AI-generated medical content, particularly when such content contains misinformation. Objectives: This study assessed the awareness, attitudes, and ability of health professions students in Riyadh, Saudi Arabia, to detect AI-generated misinformation in medical contexts. Methodology: A cross-sectional study was conducted among 354 health professions students using a structured online questionnaire. The survey captured demographics, AI usage patterns, awareness of AI concepts, verification behaviors, and the ability to identify inaccurate AI-generated statements. Descriptive and inferential analyses were performed. Results: Most students reported prior use of AI tools (86.7%), yet only half (50.0%) were aware of the term AI hallucination. A large proportion (77.7%) had previously encountered wrong or confusing AI-generated information. Despite this, only 37.9% consistently verified AI outputs using other sources. Performance on the hallucination-detection items revealed substantial gaps: only 25.1% correctly identified the false statement that magnetic resonance imaging uses ionizing radiation, 40.1% correctly recognized that vitamin C does not prevent the common cold, and 54.1% correctly affirmed the aspirin–Reye’s syndrome association. While attitudes toward AI were generally positive – with 89.3% agreeing it is a useful educational tool – significant limitations in critical appraisal skills were evident. Conclusion: Health professions students in Riyadh are active users of AI technologies but demonstrate limited ability to detect AI-generated medical misinformation. Given the high reliance on AI for academic and clinical learning, these findings highlight an urgent need to integrate structured AI literacy, critical appraisal training, and misinformation-detection exercises into health professions curricula to promote safe and responsible use of AI in healthcare.

AI-generated misinformationhealth professions studentsAI hallucinationmisinformation detection
مراجعةوصول مفتوح202421استشهاد· Semantic Scholar

The relation between Parkinson’s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis

Frontiers in Pharmacology · مجلد 15 · 1434512-1434512

Background: Parkinson’s disease (PD) is a neurological condition that typically shows up with aging. It is characterized by generalized slowness of movement, resting tremor or stiffness, and bradykinesia. PD patients’ brains mostly exhibit an increase in inflammatory mediators and microglial response. Nevertheless, a variety of non-steroidal anti-inflammatory medications (NSAIDS) offered neuroprotection in animal models and preclinical trials. Aim: The current systematic review and meta-analysis were designed to try to resolve the debate over the association of NSAID use with the development of PD because the results of several studies were somehow contradictory. Methods: An intense search was performed on Scopus, PubMed, and Web of Science databases for articles relating the incidence of PD to the use of NSAIDs. Statistical analysis of the included studies was carried out using Review Manager version 5.4.1 by random effect model. The outcome was identified as the development of PD in patients who were on NSAIDs, ibuprofen only, aspirin only, and non-aspirin NSAIDs. This was analyzed using pooled analysis of odds ratio (OR) at a significance level of ≤0.05 and a confidence level of 95%. A statistically significant decreased risk of PD was observed in patients taking NSAIDs, Ibuprofen, and non-aspirin NSAIDs. Results: The ORs of PD occurrence in patients who took NSAIDs, Ibuprofen, and non-aspirin NSAIDs were 0.88 [95% CI (0.8–0.97), p = 0.01], 0.73 [95% CI (0.53–1), p = 0.05] and 0.85 [95% CI (0.75–0.97), p = 0.01]. Meanwhile, the risk of PD in patients who took aspirin was not statistically significant. Conclusion: In conclusion, Ibuprofen, non-aspirin NSAIDs, and other types of NSAIDs could be associated with a reduction in PD risk. However, there was no association between aspirin intake and the development of PD.

Parkinson's diseasenonsteroidal anti-inflammatory drugsibuprofenaspirin
مقالوصول مغلق20241استشهاد· Semantic Scholar

Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In silico Approach: A Promising Prospect for COVID-19 Treatment

Medicinal Chemistry · مجلد 21 (5) · 425-441

Introduction: In this research aiming at combating COVID-19, we employed advanced computer-based methods to identify potential inhibitors of SARS-CoV-2 helicase from a pool of 3009 clinical and FDA-approved drugs. Methods: To narrow down the candidates, we focused on VXG, the helicase’s co-crystallized ligand, and sought compounds with chemical structures akin to VXG within the examined drugs. The initial phase of our study involved molecular fingerprinting in addition to structure similarity studies. Results: Once the compounds most closely resembling VXG (29 compounds) were identified, we conducted various studies to investigate and validate the binding potential of these selected compounds to the protein’s active site. The subsequent phase included molecular docking, molecular dynamic (MD) simulations, and MM-PBSA studies against the SARS-CoV-2 helicase (PDB ID: 5RMM). Conclusion: Based on our analyses, we identified nine compounds with promising potential as SARS-CoV-2 helicase inhibitors, namely aniracetam, aspirin, chromocarb, cinnamic acid, lawsone, loxoprofen, phenylglyoxylic acid, and antineoplaston A10. The findings of this research help the scientific community to further investigate these compounds, both in vitro and in vivo.

COVID-19 treatmentFDA-approved drugsdrug repurposingstructural similarity
مقالمفتوح (مستودع)202240استشهاد· Semantic Scholar

Phytochemical investigation and evaluation of in vitro anti-inflammatory activity of Euphorbia hirta ethanol leaf and root extracts: A comparative study

Journal of King Saud University - Science · مجلد 34 (7) · 102261-102261

Inflammation is an unpleasant complex biological condition that is with macrophages, leucocytes, and even mast cells. Many marketed effective chemical anti-inflammatory drugs are available but due to many disadvantages people are relying on the herbals with low health risk and toxicity. The research was performed to carryout the phytochemical investigation and explore the in vitro anti-inflammatory activities of leaf and roots extracts of Euphorbia hirta (EH). Dried EH parts (viz. leaf and roots) were extracted with ethanol solvent using Soxhlet method and preliminary screened for presence of various phytochemicals. The extracts were also further tested for total alkaloids, flavonoids, and phenolics. After that, anti-inflammatory activity was measured in vitro using albumin denaturation, anti-proteinase, and anti-lipoxygenase activities against conventional anti-inflammatory agent, aspirin (100 g/ml). Finally, a correlation study was generated from the results for presence of the amount of flavonoid and phenolics in connection to the activity. The result revealed the yield was higher in ethanol root extract (48.2 g) than leaf extract. Bioactive compounds alkaloids, glycosides, flavonoids, tannins, and phenolics were reported in leaf and root extracts. Further, the number of total flavonoids and phenolics showed higher in ethanolic leaf extracts (87.53 mg QE/g and 143.20 mg GAE/g). Total alkaloids content was higher in ethanolic root extracts (13.01 mg atropine/g). Ethanol EH leaf extract exhibited significant anti-inflammatory activity than root by inhibiting albumin denaturation, proteinase, and the lipoxygenase activities with 87.51 %, and 51.2 % followed by 97.30 %, and 54.21 % followed by 94.43 % and 48.21 % respectively at 100 µg/ml concentration. The results affirmed that ethanol EH leaf extract showed better anti-inflammatory activity than root extracts when evaluated with three different in vitro models and the dose dependency activity was recorded.

Euphorbia hirtaanti-inflammatory activityphytochemical screeningleaf extract
مقالوصول مفتوح2021

Epidemiology, Evaluation and Management of Anti-Phospholipid Syndrome

Journal of Pharmaceutical Research International · مجلد 33 (60B) · 1392-1399

Antiphospholipid syndrome is defined as the presence of antiphospholipid antibodies in the setting of thrombosis and/or pregnancy loss (APLS).Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory condition that affects individuals and their families in a negative and often fatal way. There are the two types of APS: Primary APS, which develops on its own, and secondary APS, which is linked to another autoimmune disorder, most often systemic lupus erythematosus (SLE). The HLA-DR7, DR4, DRw53, DQw7, and C4 null alleles have all been linked to APLS. APS is frequently misdiagnosed due to clinical diversity and a lack of diagnostic test consistency. The classification criteria were created to categorise APS patients for research reasons, but they can also be used by professionals to establish diagnoses. Unprovoked thrombosis is currently treated with long-term warfarin or another vitamin K antagonist drug. To avoid obstetric complications, low-dose aspirin and prophylactic heparin, primarily low-molecular-weight heparin, are utilised.In this article we’ll be looking at Anti-phospholipid Syndrome, it’s etiology, epidemiology, evaluation and management.

antiphospholipid syndromeantiphospholipid antibodiesthrombosismiscarriage